VISEN Pharmaceuticals

VISEN Pharmaceuticalsverified

2561.HK

Price:

$34.66

Market Cap:

$3.59B

VISEN Pharmaceuticals, an investment holding company, engages in the development and commercialization of endocrine therapies in the People's Republic of China, Hong Kong, and Taiwan. Its lead product, Lonapegsomatropin, is a once-weekly long-acting growth hormone replacement therapy for the treatment of pediatric growth hormone deficiency. The company also develops TransCon CNP (navepegritide), a long-acting prodrug of c-type natriuretic peptide for the treatment of achondroplasia; and Palopegteriparatide, a once-daily parathyroid hormone replacement therapy for the treatment of chronic hypoparathyroidism. It has strategic collaboration agreements with Shanghai Pharmaceutical and the United...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2025-03-21

Stock Exchange

HKSE

Ticker

2561.HK

The Enterprise Value as of December 2025 (TTM) for VISEN Pharmaceuticals (2561.HK) is 2.78B

According to VISEN Pharmaceuticals’s latest financial reports and current stock price. The company's current Enterprise Value is 2.78B. This represents a change of -41.17% compared to the average of 4.73B of the last 4 quarters.

VISEN Pharmaceuticals (2561.HK) Historical Enterprise Value (quarterly & annually)

How has 2561.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of VISEN Pharmaceuticals over the last ten years is 5.47B. The current 2.78B Enterprise Value has changed 4.98% with respect to the historical average. Over the past ten years (40 quarters), 2561.HK's Enterprise Value was at its highest in in the December 2024 quarter at 5.85B. The Enterprise Value was at its lowest in in the June 2024 quarter at 0.

Quarterly (TTM)
Annual

Average

5.47B

Median

5.49B

Minimum

5.07B

Maximum

5.85B

VISEN Pharmaceuticals (2561.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of VISEN Pharmaceuticals Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 8.39%

Maximum Annual Enterprise Value = 5.85B

Minimum Annual Increase = 0%

Minimum Annual Enterprise Value = 5.07B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20245.85B6.48%
20235.49B8.39%

VISEN Pharmaceuticals (2561.HK) Average Enterprise Value

How has 2561.HK Enterprise Value performed in the past?

The current Enterprise Value of VISEN Pharmaceuticals (2561.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.47B

5-year avg

5.47B

10-year avg

5.47B

VISEN Pharmaceuticals (2561.HK) Enterprise Value vs. Peers

How is 2561.HK’s Enterprise Value compared to its peers?

VISEN Pharmaceuticals’s Enterprise Value is greater than Hua Medicine (Shanghai) Ltd. (2.11B), less than Peijia Medical Limited (3.21B), less than AIM Vaccine Co., Ltd. (5.29B), less than China Resources Medical Holdings Company Limited (3.63B), less than Medtide Inc. (0), less than TYK Medicines, Inc (4.57B), less than Qyuns Therapeutics Co., Ltd. (4.22B), greater than Jacobson Pharma Corporation Limited (2.76B), less than Adicon Holdings Limited (0), less than Modern Dental Group Limited (5.13B),

Build a custom stock screener for VISEN Pharmaceuticals (2561.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VISEN Pharmaceuticals using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VISEN Pharmaceuticals (2561.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VISEN Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is VISEN Pharmaceuticals's Enterprise Value?

What is the highest Enterprise Value for VISEN Pharmaceuticals (2561.HK)?

What is the 3-year average Enterprise Value for VISEN Pharmaceuticals (2561.HK)?

What is the 5-year average Enterprise Value for VISEN Pharmaceuticals (2561.HK)?

How does the current Enterprise Value for VISEN Pharmaceuticals (2561.HK) compare to its historical average?